Skip to content

Prediabetes, Exercise, and Appetite Regulation

Alterations to Appetite Regulation Indices in Adults With Prediabetes Following Short-Term Aerobic vs. Resistance Exercise Training

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04910763
Acronym
PEAR
Enrollment
23
Registered
2021-06-02
Start date
2019-06-12
Completion date
2022-09-28
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetitive Behavior, PreDiabetes

Keywords

Resistance Exercise, Pre Diabetes, Appetite

Brief summary

The purpose of the study is to learn about how type of exercise influences measures of appetite regulation.

Detailed description

The primary objective of this study is to understand the relationship between exercise modality and appetite regulation in a population with pre-diabetes. The study includes a screening visit to ensure eligibility of participants, baseline assessments, a resistance exercise intervention, and post intervention measurements. The variables of interest include, but are not limited to, hormonal responses to exercise training pertaining to appetite, food cravings, appetite ratings. activity levels, body composition, and ten repetition-max strength. The aim of this study is to better understand the mechanisms involved in the correlation or causation of any improvements in fitness and appetite regulation in a cohort with pre-diabetes.

Interventions

BEHAVIORALResistance Exercise

Increasing strength and fitness and thereby influencing hormones and perceptions involved in appetite regulation.

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants are randomly assigned to one of the two intervention groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-50 years of age * BMI between 27-40 kg/m² * Hemoglobin A1c level between 5.7% and 6.4% * Physical Activity (less than 150 min/week moderate-intensity Physical Activity, no more than 1 session/week of resistance exercise)

Exclusion criteria

* Unstable Cardiovascular Disease * Uncontrolled hypertension * Severe hypertriglyceridemia * History of or active liver disease * Uncontrolled thyroid disease * Active cancer diagnosis * Smoking * Engaged in exercise or diet program * History of bariatric surgery * GI malabsorptive disorders * Significant diet intolerances * History of major psychiatric disorder * presence of alcohol or substance abuse; * medications affecting weight, * EI or EE in past 6 months; * women currently pregnant, lactating, less than 6 months post-partum, or postmenopausal.

Design outcomes

Primary

MeasureTime frameDescription
Changes in Appetite RatingBaseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post mealHunger/Satiety before/after consumption of a meal
Changes in Hormonal Response to FeedingBaseline: Pre-Meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / Post-intervention(Week 4) :Pre-Meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post mealAssessment of Ghrelin levels analyzed in blood samples before/after feeding.

Secondary

MeasureTime frameDescription
Changes in Physical Activity LevelsBaseline and Post-intervention(Week 4)Measured via ActivPal Monitor
Changes in Food-Related BehaviorsBaseline and Post-intervention(Week 4)Evaluated via the Food Craving Inventory
Changes in Body CompositionBaseline and Post-intervention(Week 4)Measured via BodPod
Changes in Ad libitum Energy Intake - Free LivingBaseline and Post-intervention(Week 4)3 days of free-living ad libitum energy intake (via self-report)
Change in Ad libitum Energy Intake - In labBaseline and Post-intervention(Week 4)In lab ad libitum buffet lunch (via weigh and measure methodology)
Changes in Maximal StrengthBaseline and Post-intervention(Week 4)Measurement via 10 repetition-max testing.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026